Home Fear & Greed Pools Wallets Dictionary Advertise Facebook Twitter Telegram Reddit Youtube
Market Cap:
24h Vol:
Cryptocurrencies: 13286
Markets: 104214
CoinInsight360.com logo CoinInsight360.com logo
ENG
EST
RUS
TUR
DEU
CHI
KOR
ITA
USD
USD
AED
AFN
ALL
AMD
ANG
AOA
ARS
AUD
AWG
AZN
BAM
BBD
BDT
BGN
BHD
BIF
BMD
BND
BOB
BRL
BTN
BWP
BYN
BZD
CAD
CDF
CHF
CLF
CLP
CNH
CNY
COP
CRC
CUC
CUP
CVE
CZK
DJF
DKK
DOP
DZD
EGP
ERN
ETB
EUR
FJD
FKP
GBP
GEL
GHS
GIP
GMD
GNF
GTQ
GYD
HKD
HNL
HRK
HTG
HUF
IDR
ILS
IMP
INR
ISK
JMD
JOD
JPY
KES
KGS
KHR
KMF
KPW
KRW
KWD
KYD
KZT
LAK
LBP
LKR
LRD
LSL
LYD
MAD
MDL
MGA
MKD
MMK
MNT
MOP
MRU
MUR
MVR
MWK
MXN
MYR
MZN
NAD
NGN
NIO
NOK
NPR
NZD
OMR
PAB
PEN
PGK
PHP
PKR
PLN
PYG
QAR
RON
RSD
RUB
RWF
SAR
SBD
SCR
SDG
SEK
SGD
SHP
SLL
SRD
SSP
STD
STN
SVC
SYP
SZL
THB
TJS
TMT
TND
TOP
TRY
TTD
TWD
TZS
UAH
UGX
UYU
UZS
VES
VND
VUV
WST
ZAR
ZMW
ZWL
America's Social Casino

Market Cap
24h Vol
13286
Cryptocurrencies
64.34%
Bitcoin Share
The Coin Rise 2025-06-10 09:20:43

Canary Capital Moves Toward Potential Injective-Based ETF in the US

Canary Capital Moves Toward Potential Injective-Based ETF in the US

Canary Capital has taken its first official step toward launching a U.S.-based exchange-traded fund (ETF) centered on the Injective (INJ) token. A trust named “Canary Staked INJ ETF” was registered on June 10 with the Delaware Division of Corporations, a typical early move for firms looking to eventually list an ETF tied to a digital asset. While the creation of a Delaware trust does not guarantee an ETF launch, it is often the first step before firms file for regulatory approval with the Securities and Exchange Commission (SEC). Several recent crypto ETF launches have followed this path, including products tracking Bitcoin, Ethereum, and other blockchain tokens. There are no public details yet on the structure of the INJ ETF, but the move follows Canary Capital’s earlier filing in April for an ETF involving Tron (TRX) , which aimed to generate yield by staking the token. That structure would allow the fund to earn staking rewards while holding and locking a portion of the asset to help secure the blockchain. INJ Token Sees Boost Amid ETF Speculation News of the Delaware trust helped push the price of the INJ token up 3.7% in the last 24 hours, adding to a more than 10.5% gain over the past week. The token’s rally comes alongside a modest increase in user activity and transactions on the Injective blockchain, according to data from DappRadar. The Injective network positions itself as a layer-1 blockchain optimized for artificial intelligence agents and the tokenization of real-world assets, including traditional stocks. These sectors are gaining interest as the crypto industry continues to seek practical applications that go beyond speculative trading. Asset manager 21Shares has already launched a similar product in Europe, offering an exchange-traded product (ETP) that tracks INJ and incorporates staking rewards. Canary Capital’s move appears aimed at bringing a comparable product to U.S. markets. Regulatory Hurdles Remain for Staking-Based ETFs Despite growing interest, the SEC remains cautious about ETFs tied to staked cryptocurrencies . Last month, the regulator expressed concerns about similar proposals from REX Financial and Osprey Funds, suggesting they may not meet the legal criteria required to qualify as investment companies. Still, optimism remains. Bloomberg analyst Eric Balchunas noted that REX’s legal team believes the issue can be resolved, hinting that staking ETFs could eventually gain approval if structured properly. Canary Capital has not yet responded to requests for comment on its INJ trust filing. The post Canary Capital Moves Toward Potential Injective-Based ETF in the US appeared first on TheCoinrise.com .

Most Read News

Moralis Money
Market Cap
24h Vol
64.34%
Bitcoin Share
174
Today News
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.